ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS
- 1 February 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 40 (2) , 303-311
Abstract
Purpose: To analyze and provide an overview of the incidence, management, and prevention of conjunctival erosion in Argus II clinical trial subjects and postapproval patients. Methods: This retrospective analysis followed the results of 274 patients treated with the Argus II Retinal Prosthesis System between June 2007 and November 2017, including 30 subjects from the US and European clinical trials, and 244 patients in the postapproval phase. Results were gathered for incidence of a serious adverse event, incidence of conjunctival erosion, occurrence sites, rates of erosion, and erosion timing. Results: Overall, 60% of subjects in the clinical trial subjects versus 83% of patients in the postapproval phase did not experience device- or surgery-related serious adverse events. In the postapproval phase, conjunctival erosion had an incidence rate of 6.2% over 5 years and 11 months. In 55% of conjunctival erosion cases, erosion occurred in the inferotemporal quadrant, 25% in the superotemporal quadrant, and 20% in both. Sixty percent of the erosion events occurred in the first 15 months after implantation, and 85% within the first 2.5 years. Conclusion: Reducing occurrence of conjunctival erosion in patients with the Argus II Retinal Prosthesis requires identification and minimization of risk factors before and during implantation. Implementing inverted sutures at the implant tabs, use of graft material at these locations as well as Mersilene rather than nylon sutures, and accurate Tenon's and conjunctiva closure are recommended for consideration in all patients.Keywords
This publication has 31 references indexed in Scilit:
- Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical TrialOphthalmology, 2016
- The Status ofRPE65Gene Therapy Trials: Safety and EfficacyCold Spring Harbor Perspectives in Medicine, 2015
- Stem cells for investigation and treatment of inherited retinal diseaseHuman Molecular Genetics, 2014
- Retinal implants: a systematic review: Table 1British Journal of Ophthalmology, 2014
- Stem cell therapy and the retinaEye, 2007
- Retinitis pigmentosaThe Lancet, 2006
- Epiretinale SehprothesenDer Ophthalmologe, 2005
- Visual sensations produced by optic nerve stimulation using an implanted self-sizing spiral cuff electrodeBrain Research, 1998
- Preservation of the Inner Retina in Retinitis PigmentosaArchives of Ophthalmology (1950), 1997
- Artificial Vision for the Blind: Electrical Stimulation of Visual Cortex Offers Hope for a Functional ProsthesisScience, 1974